Ann: Appendix 4C - Quarterly, page-2

I really like this. A lot of positives to be taken out of this report. I would love for someone to name a research company that has $30 million in the kitty. This should get us through at least another two years giving us more than enough time to complete both Acne and Antimicrobial studies.
I am very confident that us long term holders are going to be handsomely rewarded for our faith and patience.
What they are trying to build isn't going to happen over night, it's going to take time but there is serious upside to this companies direction.
Impressed by the staffing cost reduction too, good to see the directors keeping that 25% pay cut for 12 months. Give themselves plenty of time to prove themselves.
Goodluck holders. Onwards and upwards from here!